<?xml version="1.0" encoding="UTF-8"?>
<p>For over 200 years, LAVs have served as invaluable tools for controlling and/or eradicating infectious diseases. The idea that infection by live pathogens can confer protection against deadly infectious diseases has been employed throughout history through procedures such as variolation [
 <xref rid="B19-vaccines-08-00036" ref-type="bibr">19</xref>,
 <xref rid="B20-vaccines-08-00036" ref-type="bibr">20</xref>,
 <xref rid="B21-vaccines-08-00036" ref-type="bibr">21</xref>,
 <xref rid="B22-vaccines-08-00036" ref-type="bibr">22</xref>,
 <xref rid="B23-vaccines-08-00036" ref-type="bibr">23</xref>,
 <xref rid="B24-vaccines-08-00036" ref-type="bibr">24</xref>]. However, by the end of the 18th century, such an idea was popularized by Edward Jenner who demonstrated that inoculation with the cowpox virus, which only produced mild illness in humans, provided immunity against smallpox, a deadly disease induced by a closely related virus, the variola virus [
 <xref rid="B25-vaccines-08-00036" ref-type="bibr">25</xref>]. With this discovery, Jenner not only promoted the concept of live-attenuated vaccines, but the general concept of vaccination as well, an idea that would save hundreds of millions of lives in the following centuries. 
</p>
